Refine your search
Collections
Co-Authors
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Vyasa, Bhargava
- Obesity in India – The Omnipresent Influence
Abstract Views :293 |
PDF Views:5
Authors
Affiliations
1 Department of Pharmacy, Shri JJT University, Vidyanagari, District-Jhunjhunu, Rajasthan-333001, IN
1 Department of Pharmacy, Shri JJT University, Vidyanagari, District-Jhunjhunu, Rajasthan-333001, IN
Source
Research Journal of Pharmacology and Pharmacodynamics, Vol 5, No 4 (2013), Pagination: 220-226Abstract
Obesity is an epidemic of the 21st century, and is a major causative factor for many other metabolic disorders. According to a global estimate by the World Health Organization (WHO), in 2005 there were about 1.6 billion overweight persons aged 15 years and above and among them at least 400 million adults were obese. The revision of definition of obesity to adjust for the racial differences, by the WHO, has resulted in a higher prevalence of 1.7 billion people classified as overweight. The WHO further projects that by 2015, approximately 2-3 billion adults will be overweight and more than 700 million will be obese. The obesity epidemic is not restricted to industrialized societies; this increase is often faster in developing countries than in the developed world. In India, obesity is emerging as an important health problem particularly in urban areas, paradoxically co-existing with undernutrition. In India, even childhood obesity is a latest epidemic with a very high magnitude. In this article the magnitude of obesity, other conditions and available management options has been reviewed.Keywords
Obesity, India
References
- World Health Organization. Obesity and Overweight, Fact Sheet No. 311. September 2006.
- World Health Organization. Global Strategy on Diet, Physical Activity and Health [Internet] 2011 Nov 4 [updated 2003]. Available from http://www.who.int/dietphysicalactivity/publications/facts/obesi ty/en/#
- Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008;93(11 Suppl 1):S9-30.
- Midha T, Nath B, Kumari R, Rao YK, Pandey U. Childhood Obesity in India: A Meta-Analysis. Indian J Pediatr. Forthcoming 2011 Oct 15.
- Deurenberg P, Deurenberg-Yap M, Guricci S. Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes Rev. 2002 Aug;3(3):141-6
- Mohan V, Deepa M, Farooq S, Narayan KM, Datta M, Deepa R. Anthropometric cut points for identification of cardiometabolic risk factors in an urban Asian Indian population. Metabolism. 2007 Jul;56(7):961-8.
- Chandalia M, Lin P, Seenivasan T, Livingston EH, Snell PG, Grundy SM et al. Insulin resistance and body fat distribution in South Asian men compared to Caucasian men. PLoS One. 2007 Aug 29;2(8):e812.
- Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes. 1998 May;47(5):699-713.
- Prentice AM, Rayco-Solon P, Moore SE. Insights from the developing world: thrifty genotypes and thrifty phenotypes. Proc Nutr Soc. 2005 May;64(2):153-61.
- Zabaneh D, Chambers JC, Elliott P, Scott J, Balding DJ, Kooner JS. Heritability and genetic correlations of insulin resistance and component phenotypes in Asian Indian families using a multivariate analysis. Diabetologia. 2009 Dec;52(12):2585-9.
- Subramanian SV, Kawachi I, Smith GD. Income inequality and the double burden of under- and overnutrition in India. J Epidemiol Community Health. 2007 Sep;61(9):802-9.
- Ramachandran A, Snehalatha C, Baskar AD, Mary S, Kumar CK, Selvam S et al. Temporal changes in prevalence of diabetes and impaired glucose tolerance associated with lifestyle transition occurring in the rural population in India. Diabetologia. 2004 May;47(5):860-5.
- Ebrahim S, Kinra S, Bowen L, Andersen E, Ben-Shlomo Y, Lyngdoh T et al; Indian Migration Study group. The effect of rural-to-urban migration on obesity and diabetes in India: a cross-sectional study. PLoS Med. 2010 Apr 27;7(4):e1000268.
- Daniel CR, Prabhakaran D, Kapur K, Graubard BI, Devasenapathy N, Ramakrishnan L et al. A cross-sectional investigation of regional patterns of diet and cardio-metabolic risk in India. Nutr J. 2011 Jan 28;10:12.
- National Sample Survey Organisation (2007) Nutritional Intake in India, 2004-2005. Ministry of Statistics and Programme Implementation, Government of India.
- Bowen L, Ebrahim S, De Stavola B, Ness A, Kinra S, Bharathi AV et al. Dietary intake and rural-urban migration in India: a cross-sectional study. PLoS One. 2011;6(6):e14822.
- Chadha SL, Gopinath N, Shekhawat S. Urban-rural differences in the prevalence of coronary heart disease and its risk factors in Delhi. Bull World Health Organ. 1997;75(1):31-8.
- Bharati DR, Deshmukh PR, Garg BS. Correlates of overweight and obesity among school going children of Wardha city, Central India. Indian J Med Res. 2008 Jun;127(6):539-43.
- Srihari G, Eilander A, Muthayya S, Kurpad AV, Seshadri S. Nutritional status of affluent Indian school children: what and how much do we know? Indian Pediatr. 2007 Mar;44(3):204- 13.
- Gupta DK, Shah P, Misra A, Bharadwaj S, Gulati S, Gupta N et al. Secular trends in prevalence of overweight and obesity from 2006 to 2009 in urban asian Indian adolescents aged 14-17 years.PLoS One. 2011 Feb 23;6(2):e17221.
- Kumar HN, Mohanan P, Kotian S, Sajjan BS, Kumar SG. Prevalence of overweight and obesity among preschool children in semi urban South India. Indian Pediatr. 2008 Jun;45(6):497- 49.
- Bhardwaj S, Misra A, Khurana L, Gulati S, Shah P, Vikram NK. Childhood obesity in Asian Indians: a burgeoning cause of insulin resistance, diabetes and sub-clinical inflammation. Asia Pac J Clin Nutr. 2008;17 Suppl 1:172-5.
- Agarwal RK. Childhood obesity: emerging challenge. Indian Pediatr. 2008 Jun;45(6):443-4.
- National Heart, Lung, and Blood Institute, Obesity Education Initiative Expert Panel. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report. Obes Res. 1998 Sep;6 Suppl 2:51S-209S. 25. Schonfeld-Warden N, Warden CH. Pediatric obesity: an overview of etiology and treatment. In: Styne DM, editor. Pediatric endocrinology. Paediatric Clinic of North America. Philadelphia: WB Saunders Company; 2001. p. 361-9.
- VanItallie TB. Treatment of obesity: can it become a science? Obes Res. 1999 Nov;7(6):605-6.
- Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison's Principles of Internal Medicine. 17th ed. New York, USA: McGraw-Hill Companies, Inc; 2008. Chapter 75, Evaluation and Management of Obesity;p.472
- Halford JC. Pharmacotherapy for obesity. Appetite. 2006 Jan;46(1):6-10.
- Rössner S, Sjöström L, Noack R, Meinders AE, Noseda G. Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group. Obes Res. 2000 Jan;8(1):49-61.
- Torgerson JS, Hauptman J, Boldrin MN, Sjöström L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004 Jan;27(1):155-61.
- Li Z, Maglione M, Tu W, Mojica W, Arterburn D, Shugarman LR et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med. 2005 Apr 5;142(7):532-46.
- Mannucci E, Dicembrini I, Rotella F, Rotella CM. Orlistat and sibutramine beyond weight loss. Nutr Metab Cardiovasc Dis. 2008 Jun;18(5):342-8. Epub 2007 Oct 24.
- Kang JG, Park CY. Anti-Obesity Drugs: A Review about Their Effects and Safety. Diabetes Metab J. 2012 Feb;36(1):13-25.
- Kanekar A, Sharma M. Pharmacological approaches for management of child and adolescent obesity. J Clin Med Res. 2010 May 19;2(3):105-11.
- August GP, Caprio S, Fennoy I, Freemark M, Kaufman FR, Lustig RH et al. Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion. J Clin Endocrinol Metab. 2008 Dec;93(12):4576-99.
- Chanoine JP, Hampl S, Jensen C, Boldrin M, Hauptman J. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA. 2005 Jun 15;293(23):2873-83.
- Stumvoll M, Nurjhan N, Perriello G, Dailey G, Gerich JE. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med. 1995 Aug 31;333(9):550-4.
- Cusi K, Consoli A, DeFronzo RA. Metabolic effects of metformin on glucose and lactate metabolism in noninsulindependent diabetes mellitus. J Clin Endocrinol Metab. 1996 Nov;81(11):4059-67.
- Lütjens A, Smit JL. Effect of biguanide treatment in obese children. Helv Paediatr Acta. 1977 Apr;31(6):473-80.
- Srinivasan S, Ambler GR, Baur LA, Garnett SP, Tepsa M, Yap F et al. Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin. J Clin Endocrinol Metab. 2006 Jun;91(6):2074-80.
- Vetter ML, Faulconbridge LF, Webb VL, Wadden TA. Behavioral and pharmacologic therapies for obesity. Nat Rev Endocrinol. 2010 Oct;6(10):578-88.
- Cardiovascular Death: Leading cause of death in Diabetes
Abstract Views :216 |
PDF Views:2
Authors
Affiliations
1 Department of Pharmacy, Shri JJT University, Vidyanagari, District-Jhunjhunu, Rajasthan-333001, IN
1 Department of Pharmacy, Shri JJT University, Vidyanagari, District-Jhunjhunu, Rajasthan-333001, IN
Source
Research Journal of Pharmacology and Pharmacodynamics, Vol 5, No 4 (2013), Pagination: 249-256Abstract
Globalization, increase in the economy and the lifestyle has promoted Cardiovascular deaths as the leading cause of death amongst all causes. Diabetes; a significant risk factor of Cardiovascular disease is associated with great risk of morbidity and mortality accounting for up to two-thirds of all deaths in the diabetic population. Evidence suggests that hyperglycemia, the hallmark of diabetes, along with other associated factors contributes to myocardial damage after ischemic events and ultimately triggers the CV mortality and morbidity. Reducing coronary risk from diabetes requires a multifactorial approach to manage all atherogenic influences with change in the lifestyle manner.Keywords
Cardiovascular, Mortality, DiabetesReferences
- WHO report – The global burden of disease 2004 update.
- CVD Atlas - risk factors, 2003.
- Franco OH, Steyerberg EW, Hu FB, Mackenbach J, Nusselder W. Associations of Diabetes Mellitus With Total Life Expectancy and Life Expectancy With and Without Cardiovascular Disease. Arch Intern Med 2007;167(11):1145- 51.
- Bianchi C, Miccoli R, Penno G, Prato SD. Primary Prevention of Cardiovascular Disease in People With Dysglycemia. Diabetes Care. 2008;31(2):S208-14.
- Donahoe SM, Stewart GC, McCabe CH, et al. Diabetes and Mortality Following Acute Coronary Syndromes. JAMA. 2007;298(7):765-775.
- An update on Diabetes - www.whoindia.org/SCN/AssBOD/06- Diabetes.
- Dokken BB. The Pathophysiology of Cardiovascular Disease and Diabetes: Beyond Blood Pressure and Lipids. Diabetes Spectrum 2008;21(3):160-5.
- The National Prescribing Centre, MeReC Bulletin Volume 15, Number 1.